Germany is the European Union’s (EU) largest pharmaceutical market by revenue and has the highest medical biotechnology ...

Siren Biotechnology, a clinical-stage biotechnology company pioneering Universal AAV Immuno-Gene Therapy for cancer, today announced the appointment of Peter Bross, MD, former Chief of the Oncology ...

PRNewswire/ -- eGlint, Inc., a biotechnology company developing next-generation extremely rapid proteomics technologies, ...

High energy costs are pushing inflation concerns back into focus after crude oil moved above US$100, and that kind of ...

Spread the loveImagine a world where the agonizing wait for a new life-saving drug is drastically cut short, where illnesses ...

Insilico Medicine founder and CEO Dr. Alex Zhavoronkov details how his company is developing medicine targeting age and ...

Hong Kong's biomedical ambitions face hurdles beyond research funding, experts say, pointing to limited industry investment, ...

Biotechs must now adopt new commercial models if breakthrough treatments are to reach the patients they’re designed to help.

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, announced that it will be presenting ...

A virus known for causing serious neurological complications may hold unexpected promise against one of the deadliest forms of brain cancer.

Sensorion (FR001401A9Z0 – ALSEN), a clinical-stage biotechnology company developing treatments for hearing loss, has appointed Peter Weber, MD, MBA, as... Read More ...

Medical implants are no longer passive pieces of hardware. A titanium screw or an artificial hip must do far more than ...